Cargando…

C1q ablation exacerbates amyloid deposition: A study in a transgenic mouse model of ATTRV30M amyloid neuropathy

ATTRV30M amyloid neuropathy is a lethal autosomal dominant sensorimotor and autonomic neuropathy, caused by deposition of amyloid fibrils composed of aberrant transthyretin (TTR). Ages of onset and penetrance exhibit great variability and genetic factors have been implicated. Complement activation c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Panayiotou, Elena, Fella, Eleni, Papacharalambous, Revekka, Malas, Stavros, Saraiva, Maria Joao, Kyriakides, Theodoros
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391113/ https://www.ncbi.nlm.nih.gov/pubmed/28407005 http://dx.doi.org/10.1371/journal.pone.0175767

Ejemplares similares

Pharmacological Stimulation of Phagocytosis Enhances Amyloid Plaque Clearance; Evidence from a Transgenic Mouse Model of ATTR Neuropathy
por: Fella, Eleni, et al.
Publicado: (2017)

The role of complement in ATTR amyloidosis: a new therapeutic avenue?
por: Panayiotou, Elena, et al.
Publicado: (2015)

C5aR agonist enhances phagocytosis of fibrillar and non-fibrillar Aβ amyloid and preserves memory in a mouse model of familial Alzheimer’s disease
por: Panayiotou, Elena, et al.
Publicado: (2019)

Genetic background modifies amyloidosis in a mouse model of ATTR neuropathy
por: Panayiotou, E., et al.
Publicado: (2016)

Drug and Gene Therapy for Treating Variant Transthyretin Amyloidosis (ATTRv) Neuropathy
por: Dardiotis, Efthimios, et al.
Publicado: (2023)

Cutaneous amyloid is a biomarker in early ATTRv neuropathy and progresses across disease stages
por: Freeman, Roy, et al.
Publicado: (2022)

The hidden story behind gender differences in familial amyloid polyneuropathy (FAP) ATTRV30M
por: Santos, Diana, et al.
Publicado: (2015)

Hippocampal expression of murine IL-4 results in exacerbation of amyloid deposition
por: Chakrabarty, Paramita, et al.
Publicado: (2012)

Pharmacological activation of the C5a receptor leads to stimulation of the β-adrenergic receptor and alleviates cognitive impairment in a murine model of familial Alzheimer’s disease
por: Fella, Eleni, et al.
Publicado: (2022)

Peritubular and Perivascular Amyloid Deposits in Amyloid Nephropathy
por: Chiba, Yuki, et al.
Publicado: (2021)

β-amyloid deposition is shifted to the vasculature and memory impairment is exacerbated when hyperhomocysteinemia is induced in APP/PS1 transgenic mice
por: Sudduth, Tiffany L, et al.
Publicado: (2014)

Cerebral Amyloid Angiopathy and Parenchymal Amyloid Deposition in Transgenic Mice Expressing the Danish Mutant Form of Human BRI(2)
por: Vidal, Ruben, et al.
Publicado: (2008)

Amyloid Proteins and Peripheral Neuropathy
por: Asiri, Mohammed M. H., et al.
Publicado: (2020)

Atherosclerosis is exacerbated by chitinase-3-like-1 in amyloid precursor protein transgenic mice
por: Jung, Yu Yeon, et al.
Publicado: (2018)

Repeated treatments with rituximab in a patient with amyloid-like IgM deposition neuropathy
por: Kadoya, Masato, et al.
Publicado: (2016)

Expression of complement system components during aging and amyloid deposition in APP transgenic mice
por: Reichwald, Julia, et al.
Publicado: (2009)

Space-Dependent Glia–Neuron Interplay in the Hippocampus of Transgenic Models of β-Amyloid Deposition
por: Lana, Daniele, et al.
Publicado: (2020)

Plasmin activity promotes amyloid deposition in a transgenic model of human transthyretin amyloidosis
por: Slamova, Ivana, et al.
Publicado: (2021)

Modeling of age-dependent amyloid accumulation and γ-secretase inhibition of soluble and insoluble Aβ in a transgenic mouse model of amyloid deposition
por: Parkinson, Joanna, et al.
Publicado: (2013)

Continuation of Exercise Is Necessary to Inhibit High Fat Diet-Induced β-Amyloid Deposition and Memory Deficit in Amyloid Precursor Protein Transgenic Mice
por: Maesako, Masato, et al.
Publicado: (2013)

Plasma amyloid beta levels are associated with cerebral amyloid and tau deposition
por: Risacher, Shannon L., et al.
Publicado: (2019)

Adult spinal cord ependymal layer: a promising pool of quiescent stem cells to treat spinal cord injury
por: Panayiotou, Elena, et al.
Publicado: (2013)

Deletion of Irs2 reduces amyloid deposition and rescues behavioural deficits in APP transgenic mice
por: Killick, Richard, et al.
Publicado: (2009)

Trans ε viniferin decreases amyloid deposits and inflammation in a mouse transgenic Alzheimer model
por: Caillaud, Martial, et al.
Publicado: (2019)

Expression of endogenous mouse APP modulates β-amyloid deposition in hAPP-transgenic mice
por: Steffen, Johannes, et al.
Publicado: (2017)

Disease risk estimates in V30M variant transthyretin amyloidosis (A-ATTRv) from Mallorca
por: Cisneros-Barroso, E., et al.
Publicado: (2023)

Antibodies to human serum amyloid P component eliminate visceral amyloid deposits
por: Bodin, Karl, et al.
Publicado: (2010)

In vivo staging of regional amyloid deposition
por: Grothe, Michel J., et al.
Publicado: (2017)

On the Nature of the Waxy, Lardaceous, or Amyloid Deposit
por: Dickinson, William H.
Publicado: (1868)

Glycation exacerbates the neuronal toxicity of β-amyloid
por: Li, X-H, et al.
Publicado: (2013)

Prevalence estimation of ATTRv in China based on genetic databases
por: Yongsheng, Zheng, et al.
Publicado: (2023)

Transthyretin Amyloid Cardiomyopathy: Impact of Transthyretin Amyloid Deposition in Myocardium on Cardiac Morphology and Function
por: Nakano, Tomoya, et al.
Publicado: (2022)

Monoclonal Gammopathy of Undetermined Significance with Amyloid Deposition in the Lung and Non-Amyloid Eosinophilic Deposition in the Brain: A Case Report
por: Abi-Fadel, Francois, et al.
Publicado: (2010)

Therapeutic Trem2 activation ameliorates amyloid-beta deposition and improves cognition in the 5XFAD model of amyloid deposition
por: Price, Brittani R., et al.
Publicado: (2020)

Intracranial administration of deglycosylated C-terminal-specific anti-Aβ antibody efficiently clears amyloid plaques without activating microglia in amyloid-depositing transgenic mice
por: Carty, Niki C, et al.
Publicado: (2006)

Passive immunotherapy against Aβ in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage
por: Wilcock, Donna M, et al.
Publicado: (2004)

Disseminated Superficial Porokeratosis with Dermal Amyloid Deposits
por: Carlesimo, M., et al.
Publicado: (2009)

Cognition, Reserve, and Amyloid Deposition in Normal Aging
por: Rentz, Dorene M, et al.
Publicado: (2010)

Characterization of Amyloid-β Deposits in Bovine Brains
por: Vallino Costassa, Elena, et al.
Publicado: (2016)

Colonic Angiosarcoma Arising in Association with Amyloid Deposits
por: Said, Samar, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_as9n270dmnu4cj5mufcj2td52j